Related Experiment Videos
Expression of a soluble form of LFA-1 and demonstration of its binding activity with ICAM-1
Y Tominaga1, Y Kita, T Uchiyama
1New Product Research Laboratories III, Daiichi Pharmaceutical, Tokyo, Japan.
Insights
Researchers developed a soluble form of human lymphocyte function-associated antigen-1 (sLFA-1) to study its interaction with intercellular adhesion molecule-1 (ICAM-1). This soluble LFA-1 (sLFA-1) is a functional tool for analyzing ICAM-1/LFA-1 binding and identifying potential antagonists.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- The interaction between lymphocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is crucial for T cell activation and leukocyte migration.
- Understanding this interaction is key to modulating immune responses and inflammatory processes.
Purpose of the Study:
- To develop and characterize a recombinant soluble form of human LFA-1 (sLFA-1).
- To utilize sLFA-1 for measuring the binding kinetics between LFA-1 and ICAM-1.
- To assess the potential of sLFA-1 in screening for ICAM-1/LFA-1 antagonists.
Main Methods:
- Expression and purification of recombinant soluble human LFA-1 (sLFA-1).
- Functional assessment of sLFA-1 binding to ICAM-1 using receptor binding assays.
- Evaluation of inhibitory activity of monomeric and dimeric ICAM-1 constructs.
Main Results:
- Successfully expressed and purified functional sLFA-1.
- Demonstrated binding of sLFA-1 to ICAM-1 via receptor binding assays.
- Identified IC50 values of 400 nM for monomeric ICAM-1 and 40 nM for dimeric ICAM-1 in inhibiting sLFA-1 binding.
Conclusions:
- Recombinant soluble LFA-1 (sLFA-1) is a viable tool for studying LFA-1/ICAM-1 interactions.
- sLFA-1 facilitates molecular analysis of this critical cell adhesion pathway.
- The developed sLFA-1 assay system can be employed for screening potential ICAM-1/LFA-1 antagonists.
Abstract:
The interaction between lymphocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is of importance in a number of cellular events, including antigen-specific T cell activation and emigration of leukocytes into sites of inflammation. We describe here the first use of a recombinant soluble form of human LFA-1 (sLFA-1) for the measurement of the binding between LFA-1 and ICAM-1. sLFA-1 has been successfully expressed and purified. The expressed sLFA-1 was shown to be functionally active by their binding to ICAM-1. Binding of sLFA-1 to ICAM-1 was observed by receptor binding assay. Both monomeric (soluble ICAM-1 or the first two domains of ICAM-1) and dimeric ICAM-1 (IgG chimera of each ICAM-1 fragment) showed inhibitory activity on assay with IC50 values of 400 nM and 40 nM, respectively. These results suggest that the soluble constructs would be useful tools for molecular analysis of ICAM-1/LFA-1 interaction as well as in screening for ICAM-1/LFA-1 antagonists.